Recruitment

If you are eligible for the trial and interested in being recruited, please fill the form below and select a study site.

First Name *

Last Name *

Email Address *

Phone Number *

Study Sites *Lagos University Teaching Hospital (LUTH)Lagos State University Teaching Hospital (LASUTH)Lagos Island Maternity (LMIH)Alimosho General HospitalRandle General HospitalGbagada General HospitalIsolo General HospitalIkorodu General HospitalIfako Ijaye General HospitalIbeju-Lekki General HospitalOrile Agege General HospitalSomolu General HospitalFederal Medical Centre Ebute-MettaMother and Child Care Amuwo-OdofinAjeromi General HospitalOBAFEMI AWOLOWO UNIVERSITY TEACHING HOSPITAL (OAUTH)Select a Study Site From the List Above

How did you hear about the Trial? *

If Other, Please State *

Please do not fill in this field.

About PIPSICKLE Trial

PIPSICKLE:
Low dose aspirin for preventing intrauterine growth restriction and preeclampsia in sickle cell pregnancy.

This will be the first randomized control trial to be performed in pregnant women with sickle cell disease in Nigeria.

The researchers include a skilled team of investigators, site coordinators, and other health professionals across selected study sites in Nigeria.

Principal Investigator

Prof. Bosede B. Afolabi (MBChB, DM(Notts),
FRCOG (UK), FWACS, FMCOG)
Department of Obstetrics & Gynaecology
College of Medicine, University of Lagos/Idi-Araba, Lagos.